FREQUENCY THERAPEUTICS INC (FREQ) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:FREQ • US35803L1089

0.2996 USD
+0.02 (+5.94%)
Last: Nov 3, 2023, 08:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to FREQ. FREQ was compared to 524 industry peers in the Biotechnology industry. While FREQ seems to be doing ok healthwise, there are quite some concerns on its profitability. FREQ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • FREQ had negative earnings in the past year.
  • FREQ had a negative operating cash flow in the past year.
FREQ Yearly Net Income VS EBIT VS OCF VS FCFFREQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 0 20M -20M -40M -60M -80M

1.2 Ratios

  • The Return On Assets of FREQ (-76.59%) is worse than 70.30% of its industry peers.
  • FREQ has a worse Return On Equity (-145.99%) than 68.48% of its industry peers.
Industry RankSector Rank
ROA -76.59%
ROE -145.99%
ROIC N/A
ROA(3y)-41%
ROA(5y)-34.99%
ROE(3y)-65.47%
ROE(5y)-52.09%
ROIC(3y)N/A
ROIC(5y)N/A
FREQ Yearly ROA, ROE, ROICFREQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 -20 -40 -60 -80 -100

1.3 Margins

  • FREQ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FREQ Yearly Profit, Operating, Gross MarginsFREQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 -200 -400 -600

More info and screens

5

2. Health

2.1 Basic Checks

  • FREQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, FREQ has more shares outstanding
  • The debt/assets ratio for FREQ is higher compared to a year ago.
FREQ Yearly Shares OutstandingFREQ Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 10M 20M 30M
FREQ Yearly Total Debt VS Total AssetsFREQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

  • FREQ has an Altman-Z score of -5.79. This is a bad value and indicates that FREQ is not financially healthy and even has some risk of bankruptcy.
  • FREQ has a Altman-Z score of -5.79. This is in the lower half of the industry: FREQ underperforms 68.98% of its industry peers.
  • FREQ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.79
ROIC/WACCN/A
WACC9.02%
FREQ Yearly LT Debt VS Equity VS FCFFREQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 3.14 indicates that FREQ has no problem at all paying its short term obligations.
  • With a Current ratio value of 3.14, FREQ is not doing good in the industry: 68.48% of the companies in the same industry are doing better.
  • A Quick Ratio of 3.14 indicates that FREQ has no problem at all paying its short term obligations.
  • The Quick ratio of FREQ (3.14) is worse than 67.66% of its industry peers.
Industry RankSector Rank
Current Ratio 3.14
Quick Ratio 3.14
FREQ Yearly Current Assets VS Current LiabilitesFREQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 13.39% over the past year.
  • FREQ shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
EPS 1Y (TTM)13.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.91%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • FREQ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.00% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y31.85%
EPS Next 2Y22.39%
EPS Next 3Y13.2%
EPS Next 5Y9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FREQ Yearly Revenue VS EstimatesFREQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2028 2029 2030 50M 100M 150M 200M 250M
FREQ Yearly EPS VS EstimatesFREQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • FREQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year FREQ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FREQ Price Earnings VS Forward Price EarningsFREQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FREQ Per share dataFREQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as FREQ's earnings are expected to grow with 13.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.39%
EPS Next 3Y13.2%

More info and screens

0

5. Dividend

5.1 Amount

  • FREQ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FREQUENCY THERAPEUTICS INC / FREQ FAQ

What is the ChartMill fundamental rating of FREQUENCY THERAPEUTICS INC (FREQ) stock?

ChartMill assigns a fundamental rating of 2 / 10 to FREQ.


What is the valuation status for FREQ stock?

ChartMill assigns a valuation rating of 0 / 10 to FREQUENCY THERAPEUTICS INC (FREQ). This can be considered as Overvalued.


How profitable is FREQUENCY THERAPEUTICS INC (FREQ) stock?

FREQUENCY THERAPEUTICS INC (FREQ) has a profitability rating of 0 / 10.


What is the expected EPS growth for FREQUENCY THERAPEUTICS INC (FREQ) stock?

The Earnings per Share (EPS) of FREQUENCY THERAPEUTICS INC (FREQ) is expected to grow by 31.85% in the next year.